Peninsula Pharmaceuticals

Peninsula Pharmaceuticals

Penin­sula is a bio­phar­ma­...

Other | Northern America | Health Improvement |

 

Overview

Penin­sula is a bio­phar­ma­ceu­ti­cal com­pany focused on the devel­op­ment and com­mer­cial­iza­tion of antibi­otics to treat life-​​threatening infec­tions. The Company’s mis­sion is to develop opti­mal anti-​​infective ther­a­pies that offer improved effi­cacy, dos­ing and safety char­ac­ter­is­tics over exist­ing ther­a­pies. In addi­tion to DBL Investors, investors include Canaan Part­ners and Domain Associates.



Penin­sula was acquired by John­son & John­son on June 30th, 2005.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Peninsula Pharmaceuticals

1751 Harbor Bay Parkway
Alameda, California 94502
United States



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.